Invest In Biomed

Arnaud Debains and Sandrine Isz (BOYDSense): 'Invest In Biomed enabled us to better articulate our story.'

Arnaud Debains and Sandrine Isz (BOYDSense): 'Invest In Biomed enabled us to better articulate our story.'

March 31, 2025
Arnaud Debains and Sandrine Isz are respectively the Chief Financial Officer and Chief Science Officer of BOYDSense, a startup developing innovative respiratory analysis technology that enables patients to easily monitor their health status and manage chronic conditions, particularly diabetes. A laureate of Eurobiomed's Invest In Biomed program in 2023, BOYDSense successfully completed a fundraising round in April 2024.
Read more
No results found.